HIGHLIGHTS
- who: Sujeong Kim et al. from the Department of Biomedical Science and Engineering, Institute of Science and Technology (GIST) have published the article: Live Biotherapeutic Lactococcus lactis GEN3013 Enhances Antitumor Efficacy of Cancer Treatment via Modulation of Cancer Progression and Immune System, in the Journal: Cancers 2022, 14, 4083. of 11/01/2022
- what: Because L lactis GEN3013 reduced the proliferation of various cancer cells, the authors propose that L lactis GEN3013 could be used as a monotherapy for cancer.
- how: The results showed that the anticancer effect of the L lactis GEN3013 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.